For example, Cilengitide, an αvβ3/β5 antagonist, blocks immune cell adhesion and migration,inhibiting TGF-β–dependent myofibroblast differentiation, significantly reducing inflammatory infiltration and collagen deposition in liver and lung fibrosis models (130, 131). This evidence concerns the gene TGFB1 and pulmonary fibrosis.